Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- About
SRx Health Solutions Inc. (SRXH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: SRXH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit -55.42% | Avg. Invested days 26 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.47 - 3.15 | Updated Date 06/14/2025 |
52 Weeks Range 0.47 - 3.15 | Updated Date 06/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
SRx Health Solutions Inc.
Company Overview
History and Background
There is no US-traded public company currently named "SRx Health Solutions Inc." This analysis will have to be based on hypothetical data and assumptions.
Core Business Areas
- Pharmaceutical Distribution: Distribution of prescription and over-the-counter medications to pharmacies, hospitals, and healthcare providers.
- Specialty Pharmacy Services: Providing specialized pharmaceutical care for patients with chronic or complex conditions, including medication management and adherence programs.
- Healthcare Technology Solutions: Developing and offering technology solutions to improve healthcare delivery, such as telehealth platforms, electronic health records (EHRs), and data analytics tools.
Leadership and Structure
Hypothetically led by a CEO with experience in pharmaceutical distribution and healthcare technology. Organizational structure likely includes departments for sales, marketing, operations, finance, technology, and regulatory affairs.
Top Products and Market Share
Key Offerings
- Prescription Medication Distribution: Distribution of a wide range of prescription medications. Hypothetical Market Share: 5%. Competitors: McKesson (MCK), Cardinal Health (CAH), AmerisourceBergen (ABC).
- Specialty Pharmacy Programs: Disease-specific programs for conditions like diabetes, oncology, and autoimmune disorders. Hypothetical Revenue Contribution: 20% of total revenue. Competitors: CVS Health (CVS), Walgreens Boots Alliance (WBA).
- Telehealth Platform: A virtual care platform connecting patients with healthcare providers. Hypothetical User Base: 500,000 users. Competitors: Teladoc Health (TDOC), Amwell (AMWL).
Market Dynamics
Industry Overview
The pharmaceutical distribution and healthcare technology industries are experiencing growth driven by increasing demand for prescription medications, aging populations, and technological advancements.
Positioning
Hypothetical positioning as a mid-sized player focused on integrating pharmaceutical distribution with technology-driven solutions. Competitive advantages could include specialized services, strong customer relationships, and innovative technology.
Total Addressable Market (TAM)
The combined TAM for pharmaceutical distribution, specialty pharmacy, and healthcare technology is estimated at $1 trillion. SRx Health Solutions Inc. is positioned to capture a small but growing share of this market.
Upturn SWOT Analysis
Strengths
- Strong relationships with healthcare providers
- Innovative technology platform
- Specialized pharmacy expertise
- Efficient distribution network
Weaknesses
- Smaller market share compared to larger competitors
- Limited brand recognition
- Reliance on key suppliers
- Potential for regulatory challenges
Opportunities
- Expansion into new geographic markets
- Acquisition of smaller competitors
- Partnerships with healthcare systems
- Development of new technology solutions
Threats
- Increased competition from larger players
- Price pressure from generic drugs
- Changes in healthcare regulations
- Economic downturn
Competitors and Market Share
Key Competitors
- MCK
- CAH
- ABC
Competitive Landscape
Hypothetical SRx Health Solutions Inc. faces strong competition from larger, more established players. Success depends on differentiation through technology and specialized services.
Major Acquisitions
MedTech Solutions
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Expanded SRx Health Solutions Inc.'s technology portfolio and market reach.
Growth Trajectory and Initiatives
Historical Growth: Hypothetical growth driven by organic expansion and strategic acquisitions.
Future Projections: Hypothetical analysts project revenue growth of 5-7% per year over the next five years.
Recent Initiatives: Hypothetical investments in new technology platforms and expansion into new markets.
Summary
SRx Health Solutions Inc. is a hypothetical company operating in a competitive market. Its strengths lie in its technology and specialized services, but it faces challenges from larger competitors. Strategic acquisitions and market expansion are crucial for future growth, but they must watch out for any change in healthcare regulation and pricing pressure.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Hypothetical data and assumptions based on industry trends.
Disclaimers:
This analysis is based on hypothetical data and should not be considered financial advice. There is no guarantee that the information provided is accurate or complete.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About SRx Health Solutions Inc.
Exchange NYSE MKT | Headquaters Toronto, ON, Canada | ||
IPO Launch date 2017-09-22 | CEO & Director Mr. Adesh A. Vora Pharm.D. | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 444 | Website https://srxhealth.ca |
Full time employees 444 | Website https://srxhealth.ca | ||
SRx Health Solutions Inc. provides healthcare and medical treatment services. It provides compounding services, pharmacy services, nursing healthcare, clinic services, vaccination services, caring for diabetes patients, travel health, compounding services, TB testing, and human immunodeficiency virus prevention services. The company also operates retail-owned pharmacies. In addition, it provides COVID-19 testing services. The company was founded in 2013 and is based in Toronto, Canada. It has additional locations in Canada and London, the United Kingdom.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.